PharmaCyte Biotech, Inc. — Form 8-K
Filed October 16, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
PharmaCyte Biotech's auditor CBIZ CPAs P.C. resigned effective October 16, 2026. The auditor's letter confirms it read and agrees with PharmaCyte's Item 4.01 disclosures but explicitly states it cannot agree or disagree with other statements by the company, suggesting unresolved audit disagreements or scope limitations. No specific financial restatement, dollar amounts, or detailed reasons are disclosed in this exhibit alone.
Why this rating
Auditor resignation signals loss of confidence in financial reporting; material for $6.3M company. Raises governance/transparency risk; limits investor confidence absent full disclosure of causes.
Extracted items
Price action (we called it negative)
before filing · preread $0.34 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.